Global deletion of tetraspanin CD82 attenuates bone growth and enhances bone marrow adipogenesis
Name:
Global_CD82_KO_Bone_Manuscript ...
Size:
7.142Mb
Format:
PDF
Description:
Final Accepted Manuscript
Publisher
ELSEVIER SCIENCE INCCitation
Bergsma, A., Ganguly, S. S., Dick, D., Williams, B. O., & Miranti, C. K. (2018). Global deletion of tetraspanin CD82 attenuates bone growth and enhances bone marrow adipogenesis. Bone, 113, 105-113. https://doi.org/10.1016/j.bone.2018.05.020Journal
BONERights
© 2018 Elsevier Inc. All rights reserved.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
CD82 is a widely expressed member of the tetraspanin family of transmembrane proteins known to control cell signaling, adhesion, and migration. Tetraspanin CD82 is induced over 9-fold during osteoclast differentiation in vitro; however, its role in bone homeostasis is unknown. A globally deleted CD82 mouse model was used to assess the bone phenotype. Based on microCT and 4-point bending tests, CD82-deficient bones are smaller in diameter and weaker, but display no changes in bone density. Histomorphometry shows a decrease in size, erosion perimeter, and number of osteoclasts in situ, with a corresponding increase in trabecular surface area, specifically in male mice. Male-specific alterations are observed in trabecular structure by microCT and in vitro differentiated osteoclasts are morphologically abnormal. Histomorphometry did not reveal a significant reduction in osteoblast number; however, dynamic labeling reveals a significant decrease in bone growth. Consistent with defects in OB function, OB differentiation and mineralization are defective in vitro, whereas adipogenesis is enhanced. There is a corresponding increase in bone marrow adipocytes in situ. Thus, combined defects in both osteoclasts and osteoblasts can account for the observed bone phenotypes, and suggests a role for CD82 in both bone mesenchyme and myeloid cells.Note
12 month embargo; published online: 18 May 2018ISSN
87563282PubMed ID
29782939Version
Final accepted manuscriptSponsors
Van Andel Research Institute; Van Andel Institute Graduate SchoolAdditional Links
https://linkinghub.elsevier.com/retrieve/pii/S8756328218302102ae974a485f413a2113503eed53cd6c53
10.1016/j.bone.2018.05.020
Scopus Count
Collections
Related articles
- Regulation of cytoskeleton and adhesion signaling in osteoclasts by tetraspanin CD82.
- Authors: Bergsma A, Ganguly SS, Wiegand ME, Dick D, Williams BO, Miranti CK
- Issue date: 2019 Jun
- Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.
- Authors: Mousa A, Cui C, Song A, Myneni VD, Sun H, Li JJ, Murshed M, Melino G, Kaartinen MT
- Issue date: 2017 May
- The tetraspanin CD82 regulates bone marrow homing and engraftment of hematopoietic stem and progenitor cells.
- Authors: Saito-Reis CA, Marjon KD, Pascetti EM, Floren M, Gillette JM
- Issue date: 2018 Nov 26
- Up-regulation of BMP2/4 signaling increases both osteoblast-specific marker expression and bone marrow adipogenesis in Gja1Jrt/+ stromal cell cultures.
- Authors: Zappitelli T, Chen F, Aubin JE
- Issue date: 2015 Mar 1
- Proteinase-activated receptor-2 is required for normal osteoblast and osteoclast differentiation during skeletal growth and repair.
- Authors: Georgy SR, Pagel CN, Ghasem-Zadeh A, Zebaze RM, Pike RN, Sims NA, Mackie EJ
- Issue date: 2012 Mar